Setting Priorities for HIV/AIDS Interventions

A Cost–Benefit Approach

Robert J. Brent, Professor of Economics, Fordham University, New York, US

HIV/AIDS is much too complex a phenomenon to be understood only by reference to common sense and ethical codes. This book presents the cost–benefit analysis (CBA) framework in a well-researched and accessible manner to ensure that the most important considerations are recognized and incorporated.

‘Professor Brent’s book is a superlative addition to the HIV/AIDS policy literature. Both non-specialists and specialists in policy evaluation will benefit from the lucid exposition of cost–benefit analysis (CBA) methods applied to the most critical and far-reaching problem that challenges social institutions and individual behavior. Essentially, Professor Brent has taken his vast experience in cost–benefit analysis, and on the ground African research, to apply CBA in a compelling and insightful manner. This book re-examines HIV/AIDS policy in Sub-Saharan countries where the devastation is an infection tsunami. . . Finding what actually works may be difficult, but Professor Brent argues persuasively that using a CBA framework is the best approach.’
– William S. Cartwright, George Mason University, US

2011 240 pp Paperback 978 0 85793 250 1 £33.60 £27.00 $33.60 $42.00
2010 240 pp Hardback 978 1 84720 331 1 £115.20 £86.00 $115.20 $128.00

Elgaronline 978 1 84980 513 1

Edward Elgar Publishing Ltd. is registered in the UK at: The Lypiatts, 15 Lansdown Road,
Cheltenham, Glos GL50 2JA. Registered number: 2041703

How To Order

Online

www.e-elgar.com

Get up to 20% discount when you order online

By Email

UK/ROW: [email protected]

N/S America: [email protected]

By Phone

UK/ROW: +44 (0) 1242 226934

N/S America: +1 413-584-5551

Connect With Us

Find us on Facebook

facebook.com/EdwardElgarPublishing

Follow us on Twitter

For news, views and offers

@ElgarPublishing

Read our Blog

For news, views and debate from our authors and readers.

https://www.elgar.blog

For More Information

UK/ROW: [email protected]

N/S America: [email protected]